- Discourses of Legitimation in the News: The Case of the Cypriot Bailout2018 | Faculty of Social Sciences
- Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial2019 | Publication without faculty affiliation
- The Nexus Between Systemic Risk and Sovereign Crises2016 | Central Library of Charles University, Faculty of Social Sciences
- Implications of the 2008 financial crisis for world financial markets2009 | Faculty of Social Sciences
- Modelling interconnections in the global financial system in the light of systemic risk2014 | Central Library of Charles University, Faculty of Social Sciences
- Framing the Cypriot financial crisis: In the service of the neoliberal vision2019 | Faculty of Social Sciences
- Unusual cause of acute limb ischemia-stent fracture2010 | First Faculty of Medicine
- Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention2017 | Publication without faculty affiliation
- Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction2019 | Third Faculty of Medicine
- Remaining challenges and opportunities for improvement in percutaneous transradial coronary procedures2012 | Faculty of Medicine in Pilsen
- Percutaneous Mechanical Thrombectomy Using Rotarex (R) S Device in Acute Limb Ischemia in Infrainguinal Occlusions2017 | First Faculty of Medicine
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | Third Faculty of Medicine
- Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy2013 | Third Faculty of Medicine
- Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes2013 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study2015 | Third Faculty of Medicine
- Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial2009 | Third Faculty of Medicine
- Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI The ACCOAST-PCI Study2014 | Third Faculty of Medicine
